# Imrozia Arif, M.D. – FDA Inspection, Jul 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/imrozia-arif-md/20c3e91b-4a37-408d-929e-e3d5cfb6a4e7
Source feed: FDA_Inspections

> FDA inspection 1100365 of Imrozia Arif, M.D., July 12, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1100365
- Company Name: Imrozia Arif, M.D.
- Inspection Date: 2019-07-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.keypedia.com/companies/imrozia-arif-md/ea8b5886-d0cc-4a12-a575-c971151c18b6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c